New wireless sensor could let hydrocephalus patients monitor brain pressure at home
NCT ID NCT06402786
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new wireless sensor placed in the brain during shunt surgery for hydrocephalus. The sensor aims to let patients and caregivers monitor brain pressure from home, reducing the need for hospital scans and easing fear of shunt blockages. It is a first-in-human safety trial with 21 participants, focusing on whether the device is safe over 3 to 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Kitea ICP Sensor (a wireless device implanted in the brain during shunt surgery)
What this could lead to
If successful, this could give patients and caregivers a way to monitor brain pressure at home, potentially catching dangerous blockages early and reducing emergency hospital visits.
What could go wrong
This is a very early, small safety study with only 21 participants, so it may not prove the device works reliably. There are also risks of infection or device malfunction from the implanted sensor.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYDROCEPHALUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Auckland City Hospital
Auckland, New Zealand